Clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma who progressed after standard regimens and the analysis of the VEGFR2 polymorphism-Reference-Cited by-同舟云学术

Clinical outcomes and safety of apatinib monotherapy in the treatment of patients with advanced epithelial ovarian carcinoma who progressed after standard regimens and the analysis of the VEGFR2 polymorphism

Published:2020-07-10 Issue:3 Volume:20 Page:3035-3045
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yan Zhen¹,Gu Yuan‑Yuan²,Hu Xiao‑Di¹,Zhao Qun¹,Kang Hai‑Li ¹,Wang Miao¹,Duan Wei¹,Guan Yin²

Affiliation:

1. Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, P.R. China

2. Department of Oncology, Beijing Chao‑Yang Hospital, Capital Medical University, Beijing 100020, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of VEGFR1, VEGFR2 and VEGFR3 polymorphisms with esophageal cancer risk: a case–control study;Egyptian Journal of Medical Human Genetics;2024-08-09

2. A latent profile analysis of health-related quality of life in patients with aplastic anemia;2024-08-09

3. SEfficacy and safety of apatinib in the treatment of patients with platinum‑resistant ovarian cancer: A systematic review and network meta‑analysis;Experimental and Therapeutic Medicine;2024-07-26

4. Association of VEGFR1, VEGFR2 and VEGFR3 Polymorphisms with Esophageal Cancer Risk: A Case- Control Study;2024-01-01

5. Association of VEGFR2 Gene Polymorphisms with Clinical Outcomes of Anti-Angiogenesis Therapy in Cancer Patients: A Systematic Review and Meta-Analysis;2024